Skip to main content

CASE REPORT article

Front. Surg., 29 June 2022
Sec. Neurosurgery

Case Report: Multilevel Ossification of the Ligamentum Flavum in a Patient With Spinal Osteoblastoma

\r\nCanada T. Montgomery
Canada T. Montgomery1*Stephen P. MirandaStephen P. Miranda2Ernest NelsonErnest Nelson3Katie LoukaKatie Louka4MacLean NasrallahMacLean Nasrallah3Paul J. ZhangPaul J. Zhang3Joel SteinJoel Stein5Dmitriy Petrov\r\nDmitriy Petrov2
  • 1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States
  • 2Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, PA, United States
  • 3Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, United States
  • 4Department of Pathology, Stony Brook University Hospital, Stony Brook, New York, United States
  • 5Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, United States

Introduction: Spinal osteoblastomas are primary benign bone tumors most commonly presenting as diffuse back pain in young adults. Rarely, spinal osteoblastoma is associated with ossification of the ligamentum flavum (OLF), a form of ectopic bone formation, which can present with myelopathy. This report highlights a unique case of a patient with spinal osteoblastoma, associated OLF, and thoracic myelopathy.

Case Description: The patient presented with subtle myelopathy consisting of mid-thoracic back pain, paresthesias, and gait instability. Imaging findings were suggestive of spinal osteoblastoma with multifocal OLF. The patient was consented for thoracic decompression and stabilization at the T6-10 levels. Histopathology confirmed osteoblastoma with associated OLF. At follow up, the patient’s neurological symptoms had completely resolved.

Conclusion: This case describes management for a rare presentation of osteoblastoma with associated OLF and myelopathy. Surgeons should be wary of disproportionate neurological compromise when spinal osteoblastoma is associated with OLF. Further study is required to elucidate the pathogenesis of this condition.

Introduction

Osteoblastomas are primary benign bone tumors (14). They represent approximately 1% of all bone tumors with about 40% being localized to the spine, most commonly the cervical and lumbar regions (1, 2). These tumors are often categorized into two groups, conventional osteoblastomas and aggressive osteoblastomas, based on presentation, imaging, and histology (2). Spinal osteoblastomas most commonly present in young adult males (80% by age 30), usually with dull, diffuse back pain (14). Bone scintigraphy is the most sensitive radiographic modality for spinal osteoblastomas, however, plain radiographs, computed tomography (CT) and magnetic resonance imaging (MRI) are often used for initial characterization of the lesion (1). In general, spinal osteoblastomas can display osteoblastic and osteolytic characteristics and usually have a nidus greater than 2 cm (2). Definitive treatment consists of complete resection, and radiation and chemotherapy are considered when complete surgical resection is not possible (14).

Ectopic bone formation, particularly ossification of the ligamentum flavum (OLF), is a rare finding in osteoblastoma (57). While other reports of OLF and osteoblastoma present solely with back pain, OLF itself can present with myelopathy and spinal stenosis (5, 7). The etiology of OLF associated with spinal osteoblastoma is largely unknown. Some proposed mechanisms postulate that growth hormones and inflammatory cytokines act as mediators in OLF pathogenesis (8). Here, we present a case of spinal osteoblastoma in which associated OLF and thoracic myelopathy created important implications for surgical management that clinicians should be aware of.

Case Description

A 30-year-old obese male with a history of hypertension, hyperlipidemia and mild scoliosis presented with subtle clinical features of myelopathy. He endorsed one week of left plantar foot paresthesias exacerbated by activity, gait instability and mid-thoracic back pain. On physical examination, he had poor proprioception in his left lower extremity. CT revealed osseous lesions at T7-10 extending into surrounding paraspinal tissues causing severe spinal canal stenosis. MRI of the spine demonstrated an expansile sclerotic osseous lesion centered at the right lamina and pedicle of T9 with central lucency, enhancement and narrowing of the spinal canal at T9-10, as well as multifocal OLF most pronounced at T6-7 and to a lesser degree at T7-8 and T8-9 (Figure 1). Together, these findings were suggestive of osteoblastoma with associated OLF and reactive bone and soft tissue inflammation, often described as the osteoblastoma flare phenomenon (9).

FIGURE 1
www.frontiersin.org

Figure 1. Osteoblastoma with multilevel ligamentum flavum ossification. (A) Sagittal CT and (B) T2-weighted and (C) fat-saturation post-contrast T1-weighted MR images show an expansile osseous lesion (arrow) centered at the right T9 lamina and pedicle with a central ring of enhancement. Note associated regional sclerosis in the T8-10 vertebral bodies (white arrowheads in A) and prominent multilevel ligamentum flavum ossification (black arrowheads in A). (D–F) Corresponding axial images show central lucency within the osseous lesion with heterogenous low T2 signal and enhancement (asterisk), as well as marked canal stenosis and cord compression (arrow in E). Note also enhancing right paravertebral soft tissue (arrowhead in E and F). Ligamentum flavum ossification and epidural lipomatosis also cause significant stenosis at T6-7, T7-8 and T8-9.

The patient consented to surgical intervention and underwent thoracic decompression and stabilization. Wide laminectomies at the T6-10 levels were performed. The ligamentum flavum was found to be significantly calcified, at times requiring high-speed pneumatic drilling for removal. Decompression was carried down through the pedicle at T9 to adequately manage the critical stenosis caused by the bony mass at T9-10. After decompression, T6-10 stabilization was performed. Post-operatively, the patient had mild left lower extremity weakness which improved spontaneously within 24 h (4+/5). At his 3-month follow up visit, the patient had complete resolution of his neurological symptoms with stable imaging findings (Figure 2).

FIGURE 2
www.frontiersin.org

Figure 2. Surgical resection and decompression. (A) Sagittal T2-weighted MRI of the thoracic spine after initial resection and decompression, prior to stabilization. (B) Three-month follow up sagittal T2-weighted MRI after further decompression and stabilization, without residual spinal stenosis.

The surgical pathology report noted osteoblastoma associated with OLF. The OLF was characterized as reactive, benign chondro-osseous tissue. Histology demonstrated anastomosing trabeculae of osteoid and woven bone with prominent osteoblastic rimming and scattered osteoclastic activity. Loose fibrovascular stroma with focal hemorrhage and vascular congestion was seen between the trabeculae, consistent with the diagnosis of osteoblastoma (Figure 3).

FIGURE 3
www.frontiersin.org

Figure 3. Histopathological characteristics assessed on surgical resection. (A) The section shows the reactive, benign chondro-osseous tissue and adjacent fibrous tissue that comprised the ossification of the ligamentum flavum specimen. Scale bar, 250 µm. (B,C) Representative sections show the anastomosing trabeculae of woven bone with loose fibrovascular stroma with focal hemorrhage and congested blood vessels, consistent with osteoblastoma. Scale bar, 250 µm. (D) Area of tumor with prominent osteoblastic rimming. Scale bar, 125 µm.

Discussion

Here, we present a unique case of osteoblastoma with associated OLF and disproportionate spinal cord compromise that may create unexpected implications for surgical management. Clinicians should be wary of thoracic myelopathy associated with osteoblastoma with OLF, even if the patient is ambulatory with grossly full strength on exam, as in this case. The severity of stenosis associated with the bony mass at T9-10 and the degree of OLF calcification seen intraoperatively was more extensive than the patient’s clinical status suggested. Preoperatively, there was low suspicion that the patient would have significant cord compromise given his baseline motor exam and the absence of spinal instability on preoperative testing. Nevertheless, the patient did have mild weakness postoperatively, likely related to the spinal cord manipulation required to achieve adequate decompression at the levels with significant OLF in the setting of existing myelopathy.

Little is known about the presentation, risk factors and pathophysiology of spinal osteoblastoma associated with OLF (5, 6). Again, the rarity of this condition is further highlighted in Table 1 which provides an overview of the few reported cases in the literature. OLF alone has a unique set of risk factors and proposed mechanisms that can provide insight into the development of OLF in the presence of osteoblastoma. For instance, studies have shown a genetic predisposition among East Asian patient populations (8, 10). Additional risk factors for OLF include metabolic disturbances seen in obesity and diabetes mellitus, both of which were present in this patient (8, 11, 12). A proposed explanation is the dysregulation and imbalance of growth factors and inflammatory cytokines, such as bone morphogenetic protein (BMP) and transforming growth factor beta (TGF-beta), which play a role in the development and growth of new cartilage and bone tissue (12). Studies have shown that degenerative intervertebral disks secrete BMP and other inflammatory cytokines that may influence the local microenvironment of nearby structures like the ligamentum flavum (LF) (13, 14). In addition, OLF cells at baseline have a higher expression of osteopontin, beta-catenin, Sox9 and Runx2, which are transcription factors for osteogenesis (13, 14). Therefore, the elevated levels of inflammatory cytokines and growth factors in the local milieu of the LF could induce and maintain osteogenic signaling pathways leading to hypertrophy and OLF (13, 14). BMP-2/4 is of particular interest in the association of osteoblastoma and OLF (15). There have been reports that show increased BMP-2/4 levels are present in osteoblastomas (6). Thus, the mechanism of OLF in osteoblastoma probably involves secretion of BMP-2/4 or other factors stimulating or responding to surrounding inflammation. Patients predisposed to OLF either by genetics, biomechanics, obesity, or diabetes may then develop prominent OLF as in our illustrative case. Ultimately, further research is required to better understand the mechanism by which ectopic bone formation occurs in this disease.

TABLE 1
www.frontiersin.org

Table 1. Literature review of osteoblastoma & osteoid osteoma cases with associated ossification of the ligamentum flavum.

In conclusion, surgeons need to be aware of the implications of OLF in the setting of osteoblastoma and plan surgical interventions accordingly. Spinal osteoblastoma associated with OLF is rare with limited information in the literature to help guide management. This case emphasizes the degree of neurological compromise that may be seen in osteoblastoma with OLF and myelopathy, and close attention should be paid during patient positioning and throughout surgery.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.

Ethics Statement

Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author Contributions

CM wrote the first draft of the manuscript. CM and SM revised and edited the manuscript. SM and DP performed the surgery. CM, SM, EM, KL, MN, PZ, and JL analyzed patient data. All authors contributed to the article and approved the submitted version.

Acknowledgments

The authors appreciate the patient’s collaboration in this work.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Atesok KI, Alman BA, Schemitsch EH, Peyser A, Mankin H. Osteoid osteoma and osteoblastoma. Am Acad Orthop Surg. (2011) 19(11):678–89. doi: 10.5435/00124635-201111000-00004

CrossRef Full Text | Google Scholar

2. Galgano MA, Goulart CR, Iwenofu H, Chin LS, Lavelle W, Mendel E. Osteoblastomas of the spine: a comprehensive review. Neurosurg Focus. (2016) 41(2):E4. doi: 10.3171/2016.5.FOCUS16122

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Kan P, Schmidt MH. Osteoid osteoma and osteoblastoma of the spine. Neurosurg Clin N Am. (2008) 19(1):65–70. doi: 10.1016/j.nec.2007.09.003

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Zileli M, Cagli S, Basdemir G, Ersahin Y. Osteoid osteomas and osteoblastomas of the spine. Neurosurg Focus. (2003) 15(5):E5.15323462

PubMed Abstract | Google Scholar

5. Kojima T, Oonishi I, Kurokawa T. Ossification of the ligamentum flavum in the thoracolumbar spine of young adults report of two cases. Int Orthop. (1992) 16:75–9. doi: 10.1007/BF00182991

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Okuda S, Myoui A, Nakase T, Wada E, Yonenobu K, Yoshikawa H. Ossification of the ligamentum flavum associated with osteoblastoma: a report of three cases. Skeletal Radiol. (2001) 30(7):402–6. doi: 10.1007/s002560100324

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Osman NS, Cheung ZB, Hussain AK, Phan K, Arvind V, Vig KS, et al. Outcomes and complications following laminectomy alone for thoracic myelopathy due to ossified ligamentum flavum: a systematic review and meta-analysis. Spine (Phila Pa 1976). (2018) 43(14):E842–8. doi: 10.1097/BRS.0000000000002563

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Ren L, Hu H, Sun X, Li F, Zhou JJ, Wang YM. The roles of inflammatory cytokines in the pathogenesis of ossification of ligamentum flavum. Am J Transl Res. (2013) 5(6):582–5. PMID: 24093055

PubMed Abstract | Google Scholar

9. Crim JR, Mirra JM, Eckardt JJ, Seeger LL. Widespread inflammatory response to osteoblastoma: the flare phenomenon. Radiology. (1990) 177(3):835–6. doi: 10.1148/radiology.177.3.2243998

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Hou X, Chen Z, Sun C, Zhang G, Wu S, Liu Z. A systematic review of complications in thoracic spine surgery for ossification of ligamentum flavum. Spinal Cord. (2018) 56(4):301–7. doi: 10.1038/s41393-017-0040-4

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Endo T, Koike Y, Hisada Y, Fujita R, Suzuki R, Tanaka M, et al. Aggravation of ossified ligamentum flavum lesion is associated with the degree of obesity [published online ahead of print, 2021 Oct 6]. Global Spine J. (2021) 12: 21925682211031514. doi: 10.1177/21925682211031514

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Inamasu J, Guiot BH. A review of factors predictive of surgical outcome for ossification of the ligamentum flavum of the thoracic spine. J Neurosurg Spine. (2006) 5(2):133–9. doi: 10.3171/spi.2006.5.2.133

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Park JO, Lee BH, Kang YM, Kim TH, Yoon JY, Kim H, et al. Inflammatory cytokines induce fibrosis and ossification of human ligamentum flavum cells. J Spinal Disord Tech. (2013) 26(1):E6–E12. doi: 10.1097/BSD.0b013e3182698501

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Hoshi K, Amizuka N, Sakou T, Kurokawa T, Ozawa H. Fibroblasts of spinal ligaments pathologically differentiate into chondrocytes induced by recombinant human bone morphogenetic protein-2: morphological examinations for ossification of spinal ligaments. Bone. (1997) 21(2):155–62. doi: 10.1016/s8756-3282(97)00106-3

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Yoshikawa H, Nakase T, Myoui A, Ueda T. Bone morphogenetic proteins in bone tumors. J Orthop Sci. (2004) 9(3):334–40. doi: 10.1007/s00776-004-0764-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: spinal osteoblastoma, ossification of the ligamentum flavum, myelopathy, neurosurgery, neurological compromise

Citation: Montgomery CT, Miranda SP, Nelson E, Louka K, Nasrallah M, Zhang PJ, Stein J and Petrov D (2022) Case Report: Multilevel Ossification of the Ligamentum Flavum in a Patient With Spinal Osteoblastoma. Front. Surg. 9:890965. doi: 10.3389/fsurg.2022.890965

Received: 7 March 2022; Accepted: 1 June 2022;
Published: 29 June 2022.

Edited by:

Ziya Levent Gokaslan, Brown University, United States

Reviewed by:

Osvaldo Mazza, Bambino Gesù Children’s Hospital (IRCCS), Italy
Miao Yu, Peking University Third Hospital, China

Copyright © 2022 Montgomery, Miranda, Nelson, Louka, Nasrallah, Zhang, Stein and Petrov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Canada T. Montgomery Q2FuYWRhLm1vbnRnb21lcnlAcGVubm1lZGljaW5lLnVwZW5uLmVkdQ==

Specialty section: This article was submitted to Neurosurgery, a section of the journal Frontiers in Surgery

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.